89BIO (ETNB)
(Real Time Quote from BATS)
$9.15 USD
+0.47 (5.42%)
Updated Jun 12, 2024 11:10 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Brokerage Reports
89BIO [ETNB]
Reports for Purchase
Showing records 21 - 26 ( 26 total )
Company: 89BIO
Industry: Medical - Biomedical and Genetics
ENTRIGUE Data Significantly Exceeds Expectations; Disease- Modifying Profile Offers SoC Potential; PT to $26 on Dilution
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: 89BIO
Industry: Medical - Biomedical and Genetics
1Q Recap; ENTRIGUE SHTG Top-Line Data Readout Imminent; Moderating PT Based on Overall Pessimism in NASH Space
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: 89BIO
Industry: Medical - Biomedical and Genetics
Company: 89BIO
Industry: Medical - Biomedical and Genetics
Company: 89BIO
Industry: Medical - Biomedical and Genetics
Final Program for Our Fourth Annual Virtual NASH Investor Conference
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: 89BIO
Industry: Medical - Biomedical and Genetics
Two for One with Phase 2 SHTG Initiated and NASH Phase 1b/2a Data Coming
Provider: Piper Sandler
Analyst: Research Department